4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrazole, 95+%, 250mg

2,2-Diphenylacetic acid, 98.0%, 500g

5-Bromo-6-chloropicolinonitrile, 95.0%, 250mg

4,6-Dichloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine, 98%, 1g

6-Azido-hexanoic acid, 98.0%, 5g

1-Cyclopropyl-2-hydroxyethan-1-one, 95+%, 1g

1-[6-Chloro-4-(trifluoromethyl)pyridin-2-yl]piperazine, 97.0%, 5g

5-Chloro-3-nitropicolinic acid, 97%, 250mg

(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 250mg

(2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95.0%, 5g

(S)-1-Benzyl-3-methylaminopyrrolidine, 97.0%, 1g

Single-channel microliter pipette Pipetman® L, 10 to 100 µl, P100L, 1 piece

(3-((Trimethylsilyl)ethynyl)phenyl)methanol, 95%, 10g